NATIONAL MARROW DONOR PROGRAM

Lobbying for NATIONAL MARROW DONOR PROGRAM

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 20, 2026

Expenses

$300,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Minnesota

Official filing document

Government bodies contacted 4

HOUSE OF REPRESENTATIVES
SENATE
Transportation Security Administration (TSA)
U.S. Customs & Border Protection

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 2

HR 5160
Stem Cell Therapeutic and Research Reauthorization Act of 2025
S 4109
Stem Cell Therapeutic and Research Reauthorization Act of 2026

Lobbying activity 3

Health Issues

Reauthorization of C.W. Bill Young Cell Transplantation Program (House and Senate), H.R. 5160/S. 4109.

Budget/Appropriations

Continued funding for the C.W. Bill Young Cell Transplantation Program. Increased funding to expand patient access to transplants. Increased medical research funding.

Transportation

Donated bone marrow/cell transportation for life-saving transplant.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.